{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T16:35:18Z","timestamp":1772901318356,"version":"3.50.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273785"],"award-info":[{"award-number":["82273785"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82474134"],"award-info":[{"award-number":["82474134"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ejmech.2025.118151","type":"journal-article","created":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T19:41:30Z","timestamp":1757446890000},"page":"118151","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Discovery of a heterocyclic aromatic amide based P-gp inhibitor as coadjutant regulating autophagy against drug resistance in breast cancer"],"prefix":"10.1016","volume":"300","author":[{"given":"Wen-han","family":"Xue","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuai","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ru-yi","family":"Man","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng-fei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gong-hui","family":"Ge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-ye","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1331-2164","authenticated-orcid":false,"given":"Fan-hao","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2700-5683","authenticated-orcid":false,"given":"Ting-jian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.118151_bib1","article-title":"Effective therapy of advanced breast cancer through synergistic anticancer by paclitaxel and P-glycoprotein inhibitor","volume":"26","author":"Zhu","year":"2024","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.ejmech.2025.118151_bib2","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/path.1706","article-title":"Molecular mechanisms of drug resistance","volume":"205","author":"Longley","year":"2005","journal-title":"J. Pathol."},{"key":"10.1016\/j.ejmech.2025.118151_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117327","article-title":"Nano-drug delivery system for the treatment of multidrug-resistant breast cancer: current status and future perspectives","volume":"179","author":"Gao","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2025.118151_bib4","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/med.21739","article-title":"Chemical molecular-based approach to overcome multidrug resistance in cancer by targeting P-glycoprotein (P-gp)","volume":"41","author":"Zhang","year":"2021","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2025.118151_bib5","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrd1984","article-title":"Targeting multidrug resistance in cancer","volume":"5","author":"Szak\u00e1cs","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2025.118151_bib6","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.ejmech.2016.08.044","article-title":"Structure-activity relationship study of novel 2-aminobenzofuran derivatives as P-glycoprotein inhibitors","volume":"125","author":"Chen","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118151_bib7","doi-asserted-by":"crossref","first-page":"15979","DOI":"10.1021\/acs.jmedchem.0c01741","article-title":"Structure-based design, synthesis, and biological evaluation of new Triazolo[1,5-a]Pyrimidine derivatives as highly potent and orally active ABCB1 modulators","volume":"63","author":"Wang","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118151_bib8","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1080\/13543776.2019.1618273","article-title":"An updated patent review on P-glycoprotein inhibitors (2011-2018)","volume":"29","author":"Leopoldo","year":"2019","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejmech.2025.118151_bib9","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1021\/acs.jmedchem.7b01340","article-title":"Comprehensive synthesis of amino acid-derived thiazole peptidomimetic analogues to understand the enigmatic Drug\/Substrate-Binding site of P-Glycoprotein","volume":"61","author":"Patel","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118151_bib10","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1016\/j.bmc.2012.02.050","article-title":"Synthesis and biological evaluation of bifendate-chalcone hybrids as a new class of potential P-glycoprotein inhibitors","volume":"20","author":"Gu","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118151_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2020.153196","article-title":"Isopetasin and S-isopetasin as novel P-glycoprotein inhibitors against multidrug-resistant cancer cells","volume":"86","author":"Abdelfatah","year":"2021","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ejmech.2025.118151_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113336","article-title":"Design, synthesis and bioactivity study on 5-phenylfuran derivatives as potent reversal agents against P-glycoprotein-mediated multidrug resistance in MCF-7\/ADR cell","volume":"216","author":"Li","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118151_bib13","doi-asserted-by":"crossref","first-page":"5988","DOI":"10.1021\/acs.jmedchem.8b00335","article-title":"Discovery of 5-Cyano-6-phenylpyrimidin derivatives containing an acylurea moiety as orally bioavailable reversal agents against P-Glycoprotein-Mediated mutidrug resistance","volume":"61","author":"Wang","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118151_bib14","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.2174\/092986712800167392","article-title":"Three decades of P-gp inhibitors: skimming through several generations and scaffolds","volume":"19","author":"Palmeira","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118151_bib15","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3389\/fonc.2014.00002","article-title":"Small and innovative molecules as new strategy to revert MDR","volume":"4","author":"Zinzi","year":"2014","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejmech.2025.118151_bib16","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ejmech.2016.03.070","article-title":"Synthesis and bioevaluation of novel benzodipyranone derivatives as P-glycoprotein inhibitors for multidrug resistance reversal agents","volume":"118","author":"Chen","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118151_bib17","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/nrc2789","article-title":"ABC transporters in cancer: more than just drug efflux pumps","volume":"10","author":"Fletcher","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejmech.2025.118151_bib18","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2174\/156802609787521553","article-title":"ABC pumps and their role in active drug transport","volume":"9","author":"Colabufo","year":"2009","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118151_bib19","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1093\/jnci\/92.16.1295","article-title":"A family of drug transporters: the multidrug resistance-associated proteins","volume":"92","author":"Borst","year":"2000","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ejmech.2025.118151_bib20","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1021\/jm801389m","article-title":"Topological polar surface area defines substrate transport by multidrug resistance associated protein 1 (MRP1\/ABCC1)","volume":"52","author":"Fernandes","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118151_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115218","article-title":"Design, synthesis and biological evaluation of seco-DSP\/DCK derivatives reversing P-glycoprotein-mediated paclitaxel resistance in A2780\/T cells","volume":"250","author":"Wang","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118151_bib22","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0014-2999(00)00047-9","article-title":"Inhibition of the P-glycoprotein- and multidrug resistance protein-mediated efflux of anthracyclines and calceinacetoxymethyl ester by PAK-104P","volume":"391","author":"Marbeuf-Gueye","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118151_bib23","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1021\/acs.jmedchem.0c00337","article-title":"Discovery of potent inhibitors against P-Glycoprotein-Mediated multidrug resistance aided by late-stage functionalization of a 2-(4-(Pyridin-2-yl)phenoxy)pyridine analogue","volume":"63","author":"Ma","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118151_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116943","article-title":"Discovery of novel third generation P-glycoprotein inhibitors bearing an azo moiety with MDR-reversing effect","volume":"280","author":"Zeng","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118151_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116207","article-title":"Design, synthesis, and bioactivity evaluation of novel indole-selenide derivatives as P-glycoprotein inhibitors against multi-drug resistance in MCF-7\/ADR cell","volume":"268","author":"Yang","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118151_bib26","doi-asserted-by":"crossref","first-page":"5550","DOI":"10.1021\/acs.jmedchem.2c01999","article-title":"Novel benzo five-membered heterocycle derivatives as P-Glycoprotein inhibitors: design, synthesis, molecular docking, and anti-multidrug resistance activity","volume":"66","author":"Yang","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118151_bib27","doi-asserted-by":"crossref","first-page":"5108","DOI":"10.1021\/acs.jmedchem.7b01457","article-title":"Inhibit or evade multidrug resistance P-Glycoprotein in cancer treatment","volume":"61","author":"Waghray","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118151_bib28","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/s41467-020-20588-0","article-title":"Carbon nano-onion-mediated dual targeting of P-selectin and P-glycoprotein to overcome cancer drug resistance","volume":"12","author":"Wang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2025.118151_bib29","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.bioorg.2019.01.039","article-title":"Design, synthesis and biological evaluation of N-(4-(2-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)phenyl)-4-oxo-3,4-dihydrophthalazine-1-carboxamide derivatives as novel P-glycoprotein inhibitors reversing multidrug resistance","volume":"86","author":"Qiu","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118151_bib30","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/s41568-018-0005-8","article-title":"Revisiting the role of ABC transporters in multidrug-resistant cancer","volume":"18","author":"Robey","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejmech.2025.118151_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.116039","article-title":"Discovery of (quinazolin-6-yl)benzamide derivatives containing a 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline moiety as potent reversal agents against P-glycoprotein-mediated multidrug resistance","volume":"264","author":"Xue","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118151_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101100","article-title":"Lansoprazole (LPZ) reverses multidrug resistance (MDR) in cancer through impeding ATP-binding cassette (ABC) transporter-mediated chemotherapeutic drug efflux and lysosomal sequestration","volume":"76","author":"Ji","year":"2024","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.ejmech.2025.118151_bib33","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1126\/science.adv1201","article-title":"Decoding lysosome communication","volume":"387","author":"Pullamsetti","year":"2025","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2025.118151_bib34","article-title":"Lysosome functions in atherosclerosis: a potential therapeutic target","volume":"14","author":"Wang","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.ejmech.2025.118151_bib35","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1080\/15548627.2022.2128019","article-title":"Autophagic lysosome reformation in health and disease","volume":"19","author":"Nanayakkara","year":"2023","journal-title":"Autophagy"},{"key":"10.1016\/j.ejmech.2025.118151_bib36","doi-asserted-by":"crossref","first-page":"558","DOI":"10.3390\/cells1030558","article-title":"Autophagy and transporter-based multi-drug resistance","volume":"1","author":"Kumar","year":"2012","journal-title":"Cells"},{"key":"10.1016\/j.ejmech.2025.118151_bib37","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1158\/0008-5472.CAN-11-3396","article-title":"Cell-mediated autophagy promotes cancer cell survival","volume":"72","author":"Buchser","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2025.118151_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107099","article-title":"Natural products for combating multidrug resistance in cancer","volume":"202","author":"Chen","year":"2024","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2025.118151_bib39","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1080\/15548627.2024.2305063","article-title":"ANXA2 (annexin A2) is crucial to ATG7-mediated autophagy, leading to tumor aggressiveness in triple-negative breast cancer cells","volume":"20","author":"Koh","year":"2024","journal-title":"Autophagy"},{"key":"10.1016\/j.ejmech.2025.118151_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116647","article-title":"Discovery of pyridoquinoxaline-based new P-gp inhibitors as coadjutant against Multi Drug Resistance in cancer","volume":"276","author":"Ibba","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118151_bib41","first-page":"784","article-title":"The roles of the human ATP-binding cassette transporters P-glycoprotein and ABCG2 in multidrug resistance in cancer and at endogenous sites: future opportunities for structure-based drug design of inhibitors","volume":"4","author":"Goebel","year":"2021","journal-title":"Cancer Drug Resist"},{"key":"10.1016\/j.ejmech.2025.118151_bib42","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12935-015-0221-1","article-title":"Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp","volume":"15","author":"Alfarouk","year":"2015","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.ejmech.2025.118151_bib43","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s10549-020-05795-z","article-title":"Differential expression and prognostic relevance of autophagy-related markers ATG4B, GABARAP, and LC3B in breast cancer","volume":"183","author":"Bortnik","year":"2020","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.ejmech.2025.118151_bib44","article-title":"Icaritin represses autophagy to promote colorectal cancer cell apoptosis and sensitized low-temperature photothermal therapy via targeting HSP90-TXNDC9 interactions","volume":"12","author":"He","year":"2025","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.ejmech.2025.118151_bib45","doi-asserted-by":"crossref","DOI":"10.1063\/5.0018516","article-title":"Heterogeneous parallelization and acceleration of molecular dynamics simulations in GROMACS","volume":"153","author":"P\u00e1ll","year":"2020","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.ejmech.2025.118151_bib46","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1021\/ct7000045","article-title":"Validation of molecular dynamics simulations of biomolecules using NMR spin relaxation as benchmarks: application to the AMBER99SB force field","volume":"3","author":"Showalter","year":"2007","journal-title":"J. Chem. Theor. Comput."},{"key":"10.1016\/j.ejmech.2025.118151_bib47","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10822-010-9395-8","article-title":"Computer-aided drug design platform using PyMOL","volume":"25","author":"Lill","year":"2011","journal-title":"J. Comput. Aided Mol. Des."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342500916X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342500916X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T22:12:53Z","timestamp":1772835173000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S022352342500916X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":47,"alternative-id":["S022352342500916X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118151","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of a heterocyclic aromatic amide based P-gp inhibitor as coadjutant regulating autophagy against drug resistance in breast cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118151","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118151"}}